What is Regenxbio's price / sales?

Regenxbio (RGNX) reported price / sales of 4.9× in Q1 2026.

How has Regenxbio's price / sales changed year-over-year?

Regenxbio's price / sales increased by 115.5% year-over-year, from 2.3× to 4.9×.

What is the long-term trend for Regenxbio's price / sales?

Over 5 years (2020 to 2025), Regenxbio's price / sales has grown at a -19.4% compound annual growth rate (CAGR), from 12.6× to 4.3×.

What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Regenxbio RGNX Price / sales

Price / sales at other companies

Regeneron PharmaceuticalsREGN

5.5×+0.6×

Sarepta Therapeutics, Inc.SRPT

1×—

BiogenBIIB

2.7×+0.7×

BioMarin PharmaceuticalsBMRN

3.4×-1.2×

EyePoint, Inc. EYPT

141.2×+135×

Ultragenyx PharmaceuticalRARE

3.1×-2.7×

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Calculated from Regenxbio’s reported figures.

market cap/total revenue=4.9×

Based on the most recent quarter.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's price / sales?: Regenxbio (RGNX) reported price / sales of 4.9× in Q1 2026.
How has Regenxbio's price / sales changed year-over-year?: Regenxbio's price / sales increased by 115.5% year-over-year, from 2.3× to 4.9×.
What is the long-term trend for Regenxbio's price / sales?: Over 5 years (2020 to 2025), Regenxbio's price / sales has grown at a -19.4% compound annual growth rate (CAGR), from 12.6× to 4.3×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.